Patents, Monopoly Power, and the Pricing of Pharmaceuticals in Low-Income Nations

F. M. Scherer
Additional contact information
F. M. Scherer: Harvard University

Working Paper Series from Harvard University, John F. Kennedy School of Government

Abstract: This paper reviews the theory and historical developments that made it possible for the world's least affluent citizens to obtain the benefits of modern pharmaceutical therapy at affordable prices. Considered in turn are the theory of differential prices, the reasons why differential pricing was not widely practiced by pharmaceutical companies selling patented medicines; how low prices eventually became available, with emphasis on AIDS anti-retrovirals; and the consequences of low prices in the least developed nations for the creation of new and more effective medicines.

Date: 2013-09
New Economics Papers: this item is included in nep-com, nep-his, nep-hme, nep-ipr and nep-pr~
References: Add references at CitEc
Citations:

Downloads: (external link)
https://research.hks.harvard.edu/publications/work ... ?PubId=9099&type=WPN

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ecl:harjfk:rwp13-029

Access Statistics for this paper

More papers in Working Paper Series from Harvard University, John F. Kennedy School of Government Contact information at EDIRC.
Bibliographic data for series maintained by ().